Source comparison
Current Evidence: What Animal Models Show vs What Remains Unknown
Every published BPC-157 for sciatica research study to date uses rodent models—primarily sciatic nerve crush or transection protocols. These studies consistently demonstrate functional recovery improvements: reduced thermal hyperalgesia (pain from heat stimuli
This comparison does not assign a generated winner or score.
- Every published BPC-157 for sciatica research study to date uses rodent models—primarily sciatic nerve crush or transection protocols. These studies consistently demonstrate functional recovery improvements: reduced thermal hyperalgesia (pain from heat stimuli), improved motor coordination on rotarod tests, and normalized nerve conduction velocity measured via electromyography. A 2020 paper in the European Journal of Pharmacology reported that BPC-157 at 10 micrograms per kilogram body weight administered intraperitoneally accelerated sensory recovery by 12 days compared to vehicle controls.
- What these models don't replicate is chronic human sciatica. Rodent nerve crush injuries heal faster than human disc-related radiculopathy because rats lack the degenerative disc disease, chronic inflammatory states, and biomechanical loading patterns humans experience. A herniated L5-S1 disc in a sedentary 50-year-old involves years of accumulated collagen cross-linking, fibrotic scar tissue, and sustained mechanical compression—none of which a 14-day rat study captures.
- The dosing question remains unanswered. Animal studies use weight-based calculations (10–20 mcg/kg), which would translate to approximately 700–1,400 micrograms for a 70kg human. But absorption kinetics differ dramatically between intraperitoneal injection in rats and subcutaneous or intramuscular administration in humans. No pharmacokinetic studies have measured BPC-157 plasma half-life, tissue distribution, or receptor occupancy in human subjects. Compounding pharmacies offer BPC-157, but without clinical trial data, dosing protocols are extrapolated from veterinary use and anecdotal reports—not evidence-based medicine.